Physician

Aditi Ahlawat, M.D.

According to 2025 Medicare claims, Aditi Ahlawat, M.D. (NPI: 1104207901) practices neurology in the San Rafael, CA market, with the plurality of this provider's patient population coming from Marin, CA. This provider's primary affiliated billing organization is REGENTS UNIV OF CALIFORNIA UCSF (NPI: 1124439807; TIN: 943281662) and primary practice location at 94945-5061.

Ahlawat's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 270 traditional Medicare patients, billed 2,103 HCPCS/CPT codes, and received $55,124 in Medicare payments. The top billing code was 99205 (New patient office or other outpatient visit with a high level of medical decision making, if using time, 60 minutes or more). Part D data shows 489 prescription claims across 117 beneficiaries totaling $98,957 in drug costs, led by Nurtec Odt (Rimegepant Sulfate). Open Payments data shows 2 records totaling $33. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing did not follow a clear longitudinal pattern. Concurrently, Part D prescription costs have risen steadily, from $2,207 to $98,957. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$47K$93K2020 Medicare payment: $12,450 (USD; Tot_Mdcr_Pymt_Amt)2021 Medicare payment: $81,076 (USD; Tot_Mdcr_Pymt_Amt)2022 Medicare payment: $93,173 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $66,257 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $55,124 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
2015N/RN/RN/R
2016N/RN/RN/R
2017N/RN/RN/R
2018N/RN/RN/R
2019N/RN/RN/R
202070107$12,450
20213421,236$81,076
20224084,409$93,173
20232811,073$66,257
20242702,103$55,124

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$117K$233K2015 Drug cost: $2,207 (USD; Tot_Drug_Cst)2016 Drug cost: $7,869 (USD; Tot_Drug_Cst)2017 Drug cost: $11,725 (USD; Tot_Drug_Cst)2018 Drug cost: $1,996 (USD; Tot_Drug_Cst)2019 Drug cost: $13,877 (USD; Tot_Drug_Cst)2020 Drug cost: $10,071 (USD; Tot_Drug_Cst)2021 Drug cost: $153,753 (USD; Tot_Drug_Cst)2022 Drug cost: $233,247 (USD; Tot_Drug_Cst)2023 Drug cost: $109,427 (USD; Tot_Drug_Cst)2024 Drug cost: $98,957 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
20152141$2,207
20163469$7,869
20172167$11,725
20182761$1,996
201954171$13,877
202055206$10,071
2021101525$153,753
2022139724$233,247
2023141386$109,427
2024117489$98,957

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
99205New patient office or other outpatient visit with a high level of medical decision making, if using time, 60 minutes or more8384$150
99215Established patient office or other outpatient visit with high level of medical decision making, if using time, 40 minutes or more143186$129
95910Nerve conduction, 7-8 studies2222$72
95909Nerve conduction, 5-6 studies3333$55
95886Needle measurement of electrical activity in arm or leg muscles, complete study5591$27

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
Nurtec OdtRimegepant Sulfate13328$13,362
Aimovig AutoinjectorErenumab-Aooe17476$12,411
Ajovy AutoinjectorFremanezumab-Vfrm14392$9,856
Mycophenolate MofetilMycophenolate Mofetil241,045$1,135
GabapentinGabapentin963,935$1,032

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.2$33ABBVIE INC.
Research PaymentsReported research-related payment or transfer-of-value amount.0$0N/R
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for Aditi Ahlawat, M.D.?

Tedicare shows public-source Medicare data for Aditi Ahlawat, M.D. (NPI 1104207901), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Aditi Ahlawat, M.D. have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Aditi Ahlawat, M.D.?

Aditi Ahlawat, M.D. is linked to REGENTS UNIV OF CALIFORNIA UCSF (billing NPI 1124439807) in the available physician profile data.

Does Aditi Ahlawat, M.D. have Open Payments data?

Aditi Ahlawat, M.D. has 2 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.